Licensing authority

EMA (European Medicines Agency)

Indication(s)

Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).

AFSTYLA can be used for all age groups.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Oral Anticoagulation Reversal

Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients

Visit Oral Anticoagulation Reversal


Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

Visit Fluid Management


More information

Category Value
Agency product number EMEA/H/C/004075
Orphan designation
Date First Approved 04-01-2017
Type Medicinal product subject to restricted medical prescription
Marketing authorisation holder CSL Behring GmbH